US 11007263
Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 11007263 (Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L) held by The United States of America, as represented by the Secretary of Agriculture expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/5254, A61K39/12, A61P, A61P31/20